Residents Win a Fun Quiz Show on Emergency Medicine Fundamentals

The Mount Sinai Beth Israel team, from left: Anthony Sielicki, MD; Avir Mitra, MD; Jeffrey Nahn, MD; and Nayan Patel, MD.

A team from Mount Sinai Beth Israel recently won the Emergency Medicine Residents Association Quiz Show, competing against 12 teams of residents from across the country at the Council of Emergency Medical Directors Academic Assembly in San Antonio, Texas. In the lighthearted spirit of the contest, the Mount Sinai team wore I ♥ NY T-shirts and foam Statue of Liberty crowns; others were dressed as pirates or Dr. Seuss characters.

But the medical questions were detailed and serious. For example, when a patient has a rapidly swelling eye, what is the ocular pressure at which a vision-saving lateral canthotomy is indicated? (For the record, the answer is 40 mmHg.)

“Congratulations to our team for coming out on top in this national competition,” says Jeremy Boal, MD, President of Mount Sinai Downtown, adding, “Best uniforms ever.”

 

Honoring Leadership Excellence in Cardiovascular Care for Women

Roxana Mehran, MD, an internationally renowned clinician and researcher in the field of interventional cardiovascular disease, received the 2018 Wenger Excellence in Medical Leadership Award from WomenHeart: The National Coalition for Women With Heart Disease during a dinner on Monday, May 7, in Washington, D.C. Dr. Mehran is Professor of Medicine (Cardiology), and Population Health Science and Policy, and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute of the Icahn School of Medicine at Mount Sinai.

The Wenger Awards are named for Nanette Kass Wenger, MD, a pioneer in women’s cardiovascular medicine and research, who trained at Mount Sinai. During the award presentation, WomenHeart cited Dr. Mehran’s work in promoting the inclusion and enrollment of women in clinical research, her numerous publications related to sex-based outcomes for women with cardiovascular disease, and her involvement in multiple organizations promoting the advancement of women’s causes in cardiovascular care and professionalism. In 2017, Dr. Mehran received the Bernadine Healy Leadership in Women’s Cardiovascular Disease Award from the American College of Cardiology.

Raising Awareness for Biomedical Research

Panelists included, from left: Anthony Fargnoli, PhD, Assistant Professor, Medicine (Cardiology); Jonathan A. Cohen, DVM, Director, Center for Comparative Medicine and Surgery; Paula Croxson, PhD, Assistant Professor, Neuroscience, and Psychiatry; Yasmin Hurd, PhD; Stacey Baker, PhD, Assistant Professor, Oncological Sciences; and Randy Albrecht, PhD, Associate Professor, Microbiology. Not pictured, Giorgio Martinelli, PhD, Associate Professor, Neurology.

Seven researchers and veterinarians from the Mount Sinai Health System discussed humane animal research at a panel held at Hatch Auditorium to commemorate Biomedical Research Awareness Day (BRAD) on Thursday, April 19. They joined more than 110 other international institutions in acknowledging the important role that laboratory animals play in advancing new treatments for complex conditions that include, but are not limited to, Alzheimer’s disease, cancer, and addiction.

“Animal models that mimic the human condition can help us focus on one chemical in an effort to start to figure out new treatments,” said Yasmin Hurd, PhD, Director of the Addiction Institute at Mount Sinai, who works with rodents to study the developmental effects of cannabis. Through these studies, Dr. Hurd has found that cannabidiol—a chemical found in marijuana—can be used in humans to decrease opioid-seeking behavior.

“For a very long time, the scientific community has been quiet about animal research,” said Jaclyn R. Steinbach, BVetMed (Hons), MRCVS, Clinical Veterinarian and Instructor, Center for Comparative Medicine and Surgery, who was the organizer of the event. “We need to share what we are doing and show that we are proud.”

Gratitude and Joy at the Master’s Commencement

From left: Dennis S. Charney, MD; Commencement speaker Debrework Zewdie, PhD, who received an honorary Doctor of Humane Letters degree; Prabhjot Singh, MD, PhD, Director of The Arnhold Institute for Global Health; and Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs.

Graduates in the Biomedical Sciences master’s program, from left: Emmy Sakakibara, Arielle Strasser, and Serife Uzun.

Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences, and Professor of Pharmacological Sciences

Chukwuemeka Iloegbu, MPH, received his hood from Nils Hennig, MD, PhD, MPH, Director of the Graduate Program in Public Health.

The Graduate School of Biomedical Sciences of the Icahn School of Medicine at Mount Sinai held the 2018 Master’s Commencement on Friday, June 22, in a ceremony that celebrated the graduates’ achievements and looked ahead to their fulfilling and varied careers.

“While some of you will continue on to careers in academia, others will consider the pharmaceutical or biotech industries, community-based public health, health care administration, epidemiology, or global health. Some of you may even start your own companies,” said Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences, and Professor of Pharmacological Sciences. “Whatever career path you take, we hope you will remain in touch with the Icahn School of Medicine—a home you can always come back to for mentoring, career advice, respect, and appreciation.”

In total, 165 students were conferred master’s degrees, including 93 in Public Health, 25 in Biomedical Sciences, 19 in Health Care Delivery Leadership, 11 in Clinical Research, 10 in Genetic Counseling, 5 in Biostatistics, and 2 in Biomedical Informatics. At the MD/PhD Commencement in May, an additional 7 MD/Master of Public Health degrees and 5 MD/Master of Science in Clinical Research degrees were conferred.

The master’s ceremony often returned to the theme of gratitude. Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, asked the graduates to thank the “parents, grandparents, siblings, spouses, and friends” present, saying, “I know that you helped set the path for each of these students to achieve their greatest potential.”

The graduates were challenged to “tackle the hard issues, the seemingly intractable ones,” by Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs, Nash Family Professor of Neuroscience, and Director of The Friedman Brain Institute. One such problem is the epidemic of opioid addiction, he said, which costs the nation $80 billion a year and kills 115 Americans a day. “We need you to confront these difficult questions of our time, knowing that there are few simple solutions and that success will require your bold imagination and working across many disciplines to improve our nation’s public health,” Dr. Nestler said.

The commencement speaker, Debrework Zewdie, PhD, former Director of the World Bank Global HIV/AIDS Program, was awarded an honorary Doctor of Humane Letters degree for her distinguished career in public health. She spent two decades at the World Bank, where she said she often felt like “a mouse in a lion’s den” as she tried to raise awareness and increase funding for the group’s fight against AIDS. By 2000, the level had reached $1 billion, funding programs that have saved millions of lives, she said.

As she stood at the podium, Dr. Zewdie first acknowledged the outside world: “Let us all take a moment to think about the thousands of children who are separated from their families at the border,” she said.

Dr. Zewdie began and ended her address with a focus on children who are “born in the ‘wrong’ part of the world” with limited access to education and health care. She told story of a 5-year-old girl in Ethiopia who was blinded by the measles for 15 days, recovered, then contracted dysentery a few months later. As one of four children of a single mother, growing up on a struggling farm, the girl faced tough odds. But she grew stronger, drinking fortified milk provided by UNICEF and becoming a voracious reader with encouragement from her older brother.

The little girl is now “standing in front of you,” Dr. Zewdie said, pausing as the audience realized it was her. And in the crowd was a slim man with white hair. It was her brother, Girma Moguss, who had supported her journey from a village school to the University of London and Harvard University. She asked him to stand, and the crowd applauded loudly, a show of gratitude that moved her and many others to tears.

“Dear graduates, if I—the 5-year-old from a very humble background— could not only beat the measles and dysentery but could also do well enough to be recognized today, then for you the sky is the limit,” Dr. Zewdie said. “Go and make the world a better place.”

Celebrating Trailblazer Pamela Sklar, MD, PhD

Luminaries in the study of psychiatric genomics joined the Mount Sinai community in celebrating the work of the late Pamela Sklar, MD, PhD, a groundbreaking psychiatrist and neuroscientist who made major discoveries that established the genetic roots of mental illness.

In her honor, the Icahn School of Medicine at Mount Sinai launched the annual “Advances in Psychiatric Genomics” lecture, held on Monday, April 16, in Goldwurm Auditorium, and renamed the division she created—now one of the best in the nation—the Pamela Sklar Division of Psychiatric Genomics. Dr. Sklar was Chair of the Department of Genetics and Genomic Sciences.

Celebrating her trailblazing research—and presenting their own—were scientists from the National Institute of Mental Health, Harvard University, the University of Pennsylvania Perelman School of Medicine, and the Icahn School of Medicine, among others. Attendees also included Dr. Sklar’s husband, Andrew Chess, MD, Professor of Genetics and Genomic Sciences; Cell, Developmental and Regenerative Biology; and Neuroscience; and their children, Michael and Isabel. The day after the event, the inaugural “Get Psyched” 5k Run/ Walk was held in Central Park to benefit the newly named division.

“Pamela was perhaps one of the bravest people I’ve ever met,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “She led a revolution in the study of the genetic basis of mental illness, showing that hundreds of genes are implicated, not just a handful as was previously believed. It took courage to challenge the prevailing point of view.”

“With a keen intellect and an unusual force of personality, Dr. Sklar was both an outstanding scientist who changed the field of psychiatric disease and a beloved mentor to students and young scientists,” said Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience; Director of The Friedman Brain Institute; and Dean for Academic and Scientific Affairs.

Kristen Brennand, PhD, Associate Professor, Genetics and Genomics, Neuroscience and Psychiatry, added: “In memory of Pamela Sklar, it was incredibly meaningful to spend a day surrounded by her closest friends and collaborators, hearing stories of the psychiatric genetics of lore as well as the newest insights from cutting-edge genetic research.”

 

At the inaugural “Advances in Psychiatric Genomics” lecture in honor of Pamela Sklar, MD, PhD, were, from left: Dennis S. Charney, MD; Isabel Sklar Chess; Andrew Chess, MD; Michael Sklar Chess; and Eric J. Nestler, MD, PhD.

Participants in the “Get Psyched” 5k Run/Walk.

Mount Sinai Doctors Faculty Practice Receives Two Patient Access Awards

Mount Sinai Doctors Faculty Practice leaders, from left: Andrew Mencher, Project Manager; Seth Ciabotti, Vice President of Ambulatory Operations; Sadiqa Horne, RN, BSN, Director of Access Center Operations; and Urvi Shah, Senior Data Analyst.

The Mount Sinai Doctors Faculty Practice has received two Best Practice Awards from the Patient Access Symposium (PAS), a group of 80 medical centers nationwide. At the awards event in May, hosted by Indiana University Health in Indianapolis, Mount Sinai staff accepted a PAS award for the use of technology in systems that give patients easy access to services like appointment scheduling and referrals. In addition, the practice’s Access Center was honored for the efficiency of its call center management. “We greatly appreciate the efforts of the Access Center leadership and staff members,” says Brian T. Smith, Senior Vice President and Chief Operating Officer of the Mount Sinai Doctors Faculty Practice. “This accomplishment was made possible by their seamless coordination and creative solutions, which are driving exceptional patient-centered care.”

The Mount Sinai Doctors Faculty Practice was invited into PAS in 2015, joining institutions including the Mayo Clinic, Duke Medicine, Rush University Medical Center, Yale Medicine, New York-Presbyterian Hospital, Northwell Health Physician Partners, UCLA Medicine, Virginia Mason Medical Center, Weill Cornell Physician Organization, University of Pennsylvania Health System, Henry Ford Health System, and Brigham and Women’s Health Care.

The criteria for the PAS awards included: achieving outcomes that improve patient access; establishing quantifiable results that exceed key performance indicators for patient access; and seeking novel, creative solutions that advance patient access beyond the status quo and improve the quality and safety of care.

Pin It on Pinterest